The financial markets are signaling that the acute phase of the euro-zone financial crisis may be over and the crisis may be shifting into a chronic phase or more precisely, a chronicphase with likely acute interludes in which panic escalates.
Just three months before its planned split into two companies, Abbott Laboratories is suffering a significant setback after a Phase III trial for a chronic kidney disease treatment was ended due to an excessive number of deaths and serious adverse events in patients.